[1]
R. Srivastava and N. D. Kantharia, “Evaluation of rationality of fixed dose combinations of antimicrobials available in Indian market”, Int J Basic Clin Pharmacol, vol. 11, no. 2, pp. 128–131, Feb. 2022.